INSIGHTS ON CRITICAL ENVIRONMENTS
-
![Factory cleanroom-GettyImages-1294339649]( "Lessons Learned From Containment Performance Verification Activities")
Lessons Learned From Containment Performance Verification ActivitiesEnsure containment performance during active powder handling. Discover how human factors and airflow dynamics influence downflow booth protection.
-
![VPE With Perry]( "A System For Annex 1 Data, Reporting, And Interpretation Requirements")
A System For Annex 1 Data, Reporting, And Interpretation RequirementsWatch this tech expo video to discover how multi-dimensional sensor placement and integrated data dashboards optimize cleanroom environmental monitoring for Annex 1 compliance.
-
![Successful_FAT_of_Filling_Line_Isolator_for_Creative_Lifesciences,Taiwan-_FAT_banner]( "Ensuring Performance And Compliance: Successful FAT Of Filling Line Isolator For Creative Lifesciences, Taiwan")
Ensuring Performance And Compliance: Successful FAT Of Filling Line Isolator For Creative Lifesciences, TaiwanRigorous Factory Acceptance Testing ensures filling line isolators meet performance and safety standards. This validation is vital for aseptic integrity and protecting both product and operator.
-
![GettyImages-1585548490-modular-facility-laboratory-drug-development]( "Insights Into Evionnaz's new R&D Center")
Insights Into Evionnaz's new R&D CenterPharmaceutical innovation depends on speed and smarter decisions. Discover how advanced R&D technologies and real-time insights are helping accelerate development.
-
The Status Quo Of Oligonucleotides Is Not The Future12/2/2024
The oligonucleotide field is booming, but manufacturing challenges loom. Experts discuss optimizing production for these promising therapies with flexible, sustainable, and high-yield approaches.
-
What Your Biological Indicator Strategy Might Be Missing7/28/2026
While biological indicators have long been the industry standard for evaluating bio-decontamination cycles, faster, cheaper, and quantifiable contamination detection technologies are emerging.
-
Automated Bioburden Testing Solution11/7/2025
Automation is transforming microbial quality control labs, boosting productivity, minimizing errors, and ensuring data integrity. Discover how digitalization is driving Pharma 4.0 and reshaping lab workflows.
-
Cleanroom Changes In 2026 For Better Contamination Control12/3/2025
Proactively improve your cleanroom strategy for 2026. Gain actionable insights on leveraging Environmental Monitoring data, optimizing personnel, and managing residue to enhance contamination control.
-
How To Double Up With A CDMO To Reduce Risk12/12/2025
Parallel operations with a CDMO can reduce risk and accelerate timelines by enabling simultaneous process development and manufacturing. Learn how this approach supports facility design.
CRITICAL ENVIRONMENT SOLUTIONS
-
![Modular-Cleanrooms]( "Modular Cleanrooms For Cell Therapy And Gene Therapy Drug Manufacturing")
Since 2000, the AES team has been working with companies in their development of autologous and allogeneic cell and tumor processing technologies. As this market segment has evolved (and continues to evolve), AES has continued to work with clients to develop modular cleanroom technology that drives efficient, safe, and compliant process operations.
-
![O'Hara Labcoat Coating Pan]( "Used 36\" O'Hara Labcoat Coating Pan, Model LC3")
O'Hara Labcoat Tablet Coating System LC3, SN 4050, New 8/2011, capacity 10-79kg @ 0.8kg/L, RPM 3-24, 3/60/460V. Includes (2) Pans (30” and 36”) each with a transport cart. System is located in 4 crates. Crate 1-Contains Main Machine/LC3 (pan currently not installed), Crate 2-contains electrical control panel and HMI control panel, Crate 3- contains O'Hara 36" Tablet Coating Pan, with storage cart. Crate 4 contains O'Hara 30" Tablet Coating Pan, with storage cart.
-
![Aseptic Filling GettyImages-1087219366]( "A Comprehensive Approach To Cleaning & Disinfection")
Ensure compliance, operational efficiency, and contamination control through tailored cleaning and disinfection solutions like validated programs, technical support, and sterile products.
-
![Cleanrooms For Cell And Gene Manufacturing Operations]( "Cleanrooms For Cell And Gene Manufacturing Operations")
Don't let the traditional cleanroom design build process delay getting therapies into the hands of those who need it most. When deadlines matter AES has the knowledge and technology to rapidly execute your cleanroom project. AES has built more cell & gene therapy cleanrooms than anyone else in the world. Why have cell & gene therapy clients selected AES? Because we understand and will meet the critical nature of your deadlines. Our system provides the speed, flexibility, and risk reduction to ensure that your facility is built on time and on budget.
-
![Pharma-Clearoom-facilities]( "Pharmaceutical Cleanroom Facilities For Sterile Drug Manufacturing")
In the spectrum of pharmaceutical manufacturing facilities, injectable product manufacturing facilities represent the most sophisticated and challenging to design, build, qualify and operate, particularly when products manufactured in these facilities are rendered sterile when complete, ready to inject directly into a human. For this reason, very careful consideration must be made when developing such a facility.
FREE CLEANING VALIDATION E-BOOK
Learn how to employ science-, risk-, and statistics-based approaches to cleaning and cleaning validation at your facility with this free, 100-page e-book, written by a global team of cleaning validation experts, pharmaceutical toxicologists, statisticians, and Six Sigma professionals.
